跳至主要内容
临床试验/NCT02315105
NCT02315105Unknown不适用

Resolution of Comorbidities & Safety and Efficacy of Greater Curvature Plication in Obese Patients

Singh, Kuldeep, M.D., P.A.2 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2011年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
75
试验地点
2
主要终点
Percent excess weight loss

研究概览

简要总结

The purpose of this study is to find out more about the safety and effectiveness of the Laparoscopic Greater Curvature Plication (LGCP) procedure in patients with obesity and related problems such as diabetes, hypertension, high cholesterol, mild obstructive sleep apnea, and joint problems. LGCP is a less invasive weight loss surgery procedure than some of the other weight loss surgeries and it is possible that there are fewer risks with this procedure than with the other weight loss surgeries. LGCP is considered an experimental procedure and this study is being done to look at the long-term outcomes.

详细描述

LGCP is a procedure in which the stomach is folded inwards to that its capacity to hold amounts of food is decreased. This is done under general anesthesia. The operation takes about an hour and is done laparoscopically. Laparoscopic approach entails placing 4-5 small incisions in the abdomen around the umbilicus and filling the abdomen with CO2 through the small tubes called Trocars. this helps life the abdominal wall and create space so that the surgeon can carry out his/her work using long instruments with thickness similar to a regular lead pencil.

The attachments of the stomach to the spleen are freed up and the outside is folded inside and stitched up to keep it from folding in. To ensure that the surgeon has not obstructed the passage in or out of the stomach, a tube is placed in the stomach at the time of the creation of the fold and checked again at the end of the procedure with a camera in the stomach which is placed through the mouth to ensure the desired outcome is achieved. At the conclusion of the procedure, the skin is closed with absorbable sutures and adhesive tapes are applied to the skin. The patient recovers in the recovery room for about an hour and a half prior to coming to their room in the hospital.

The post operative visit will be up to 7 days after the procedure. During this visit, medical information will be obtained including information about medications.

There will be follows 3-10 after the surgery. These visits may include:

  • obtaining medical information about the patient, including the medical conditions and medications
  • Checking the patient's weight
  • Blood tests
  • Endoscopic evaluation of the stomach if necessary.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject is willing to give consent and comply with evaluation and treatment schedule
  • 18 to 65 years of age
  • Have a BMI > 30 with one or more significant co-morbid medical conditions which are generally expected to be improved, reversed, or resolved by weight loss. these conditions include but are not limited to:
  • Hyperlipidemia
  • Type 2 diabetes
  • Mild Obstructive Sleep Apnea
  • Hypertension
  • Osteoarthritis of the hip or knee
  • Agree to refrain from any type of weight-loss drug ( prescription or OTC) or elective procedure that would affect body weight for the duration of the trial
  • HbA1C < 11 %
  • For subjects who have Type 2 Diabetes, the anti-diabetic medication regimen is no more complex than oral metformin plus one oral sulfonylurea plus once daily insulin injection.
  • Ability to self-pay for the procedure and follow up.

排除标准

  • 未提供

研究组 & 干预措施

Morbid Obese patients

Experimental

This purpose of this study is to find out more about the safety and effectiveness of the Laparoscopic Greater Curvature Plication (LGCP) for Morbid Obese Patients with related problems such as diabetes, hypertension, high cholesterol, mild obstructive sleep apnea and joint problems.

干预措施: Laparoscopic Greater Curvature Plication (Procedure)

结局指标

主要结局

Percent excess weight loss

时间窗: 1 year

次要结局

  • Resolution of Comorbidities(1 year)

研究者

发起方
Singh, Kuldeep, M.D., P.A.
申办方类型
Indiv
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验